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1 Introduction
Nowadays, if a company wants to be success-
ful within a market and keep up with the fierce
competition, it needs to focus on success factors
which lead to value-oriented procurement.
Value-oriented procurement makes a substan-
tial contribution to lowering material/non-person-
al and process costs, reducing the amount of cap-
ital required, and minimizing procurement risks. It
also facilitates progress and innovation. Therefore,
procurement should have an absolute command
of three key areas: “Strategy and Innovation”, “Net-
works, Cooperation and Integration”, and “Process-
es, Technology and Standards”.
Since procurement plays an important role in
terms of increasing the value of a company, an early
inclusion of procurement is substantial in the con-
text of achieving success and not being left behind
when compared to other companies. In spite of
this, there is still a large number of companies which
do not make full use of the success factor that is
procurement, as well of its development potential. 
This is also the case with companies in the chem-
ical and pharmaceutical industry which have not
fully exploited their potential in terms of achiev-
ing a higher procurement performance. In order to
achieve that, they should focus on developing a
procurement strategy and work on enhancing the
sway factors which will be presented in the main
section of the paper. 
When exploring procurement strategies, cer-
tain facts should be kept in mind, i.e. that 90% of
chemical production is based on carbon compounds,
which are mainly obtained from petroleum deriv-
atives, e.g. naphtha, ethylene, propylene, benzene,
phenol. Important markets in the chemical indus-
try are China and India, and these are largely respon-
sible for the supply of the so important commodi-
ties (BIP "Best in Procurement", 2011).
2 How value-oriented is your procure-
ment? – 2012 survey of top managers
2.1 Survey - Participants and Industrial Structure
In 2012, ConMoto conducted a survey “How
value-oriented is your procurement?” among 111
companies from German speaking countries (Ger-
many, Austria and Switzerland) to evaluate their
procurement. ConMoto Consulting Group has sum-
marized the findings of the survey, possible future
fields of action and the success factors which lead
to value-oriented procurement in the form of a
study whose content will be presented in this paper.
The survey covered eight industrial sectors: serv-
ice providers, mechanical and plant engineering,
metal and electrical industry, automotive, chemi-
cal, pharmaceutical and medical technology, build-
ing sector, energy and energy suppliers and other
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The paper discusses the ﬁndings of a survey which was conducted in 2012 by Con-
Moto Consulting Group among top managers in German speaking countries. The
aim of the survey was to analyze the value orientation of companies from a varie-
ty of industrial sectors, i.e. to evaluate the companies’ procurement. This paper
brieﬂy presents the overall ﬁndings, but the main focus is on the results of the che-
mical, pharmaceutical and medical technology sector. Finally, the success factors
which lead to value-oriented procurement are outlined.
(this category includes companies from aviation,
food and also consumer goods sectors as well as
print products, yarn, furniture and packaging man-
ufacturers). It comprised a sample of listed com-
panies as well as small and medium-sized enter-
prises (SMEs). 
Top managers from these 111 companies rated
their procurement on the basis of eleven core state-
ments and by applying a grading system from 1
(“very good”) to 6 (“unsatisfactory”). The first nine
statements aimed at evaluating the sway factors
that impact value-oriented procurement, and the
core statements ten and eleven were used to pro-
vide a final evaluation in terms of how satisfied the
companies are with the contribution procurement
makes to their success, and to explore its develop-
ment potential.
2.2 Core Sway Factors
The evaluation was based on the following nine
core sway factors and their underlying core state-
ments (ConMoto Group GmbH, 2012):
1. Sway factor: Procurement Strategy 
The core statement underlying this sway fac-
tor is: An up-to-date procurement strategy
derived from your business strategy is in place.
A development program has been defined for
implementation and communicated to all par-
ties involved in the process.
2. Sway factor: Organization and Procurement
Process
The core statement underlying this sway fac-
tor is: The procurement process in your compa-
ny is fast, flexible and efficient. Procurement is
integrated across all stages of the process early
on (cross-functional operation).
3. Sway factor: Employee Qualification
The core statement underlying this sway fac-
tor is: You are satisfied with the qualifications
and the flexibility of your procurement staff.
4. Sway factor: Decision Efficiency
The core statement underlying this sway fac-
tor is: The decisions awarding contracts (prices,
terms and conditions and content) to your sup-
pliers are systematically reached and document-
ed, with all internal partners involved in the
process casting a vote.
5. Sway factor: Material Group Management
and Cost Transparency
The core statement underlying this sway fac-
tor is: Your procurement department has bun-
dled the goods and services to be procured in a
systematic effective and cost-transparent man-
ner.
6. Sway factor: Supplier Management
The core statement underlying this sway fac-
tor is: Your suppliers’ potential for innovation
and adding value is known and transparent.
There are constant efforts to tap this potential.
7. Sway factor: Risk Management
The core statement underlying this sway fac-
tor is: Your procurement department consis-
tently takes steps to hedge against risks, e.g.
arising from volatile procurement markets or
the threat of supplier insolvencies.
8. Sway factor: Intensifying Competition
The core statement underlying this sway fac-
tor is: Your company is familiar with and uses
global supplier markets and specifically “devel-
ops” intense competition.
9. Sway factor: Performance Management
The core statement underlying this sway fac-
tor is: Procurement performance and/or the
value contributed by procurement within your
company are measured and reported to the
company’s management.
In spite of the negative outcome within some
sectors, the survey has shown that there is still sub-
stantial room for improvement, which would even-
tually enhance the company’s results and liquidi-
ty. 
3 Results for the Chemical, Pharmaceuti-
cal and Medical Technology Cluster
3.1 Grades awarded for the Core Sway Factors 
This paper has, so far, addressed some general
issues related to the study design, i.e. its partici-
pants and industrial structure, but will, in terms of
the above listed nine sway factors, mainly focus on
one particular industrial sector, i.e. chemical, phar-
maceutical and medical technology (ConMoto
Group GmbH, 2012).
Every industry has its own characteristics and
specific features, and so does the chemical, phar-
maceutical and medical technology sector. In this
industry, the qualitative requirements are very high,
and thus strong supplier relationships are essen-
tial. The partial geographical bond together with
choosing the adequate improvement method also
present challenges which need to be taken into
account in order to increase and, to the greatest
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possible extent, optimize the results and findings
from the chemical, pharmaceutical and medical
industry which have been listed in the study.
The industrial procurement of chemical and
pharmaceutical products and materials is subject
to very specific and extremely critical challenges.
The crude oil price coupling is reflected in the very
volatile markets. The result is that a hedge is hard-
ly possible, let alone the possibility to calculate eco-
nomically. 
A geographical bond, depending on location of
recovery and production of materials or compo-
nents, has partially a significant anti-competitive
effect. The same effects come from situational and
structural factors such as material losses and mar-
ket adjustment. Long-term supply contracts, verti-
cal integration (backward integration), and increas-
ing the resource efficiency can help in this situa-
tion and ensure supply.
3.1.1 Procurement Strategy
Regarding the first sway factor Procurement
Strategy, the chemical, pharmaceutical and med-
ical technology cluster lags far behind – with 18%
of the decision makers declaring that they have no
procurement strategy, and 27% rating their pro-
curement strategy as patchy. The results are relat-
ed to the failure to develop a general coordinated
business strategy that is communicated within the
company, and thus an adequately communicated
procurement strategy. Not only do companies have
to formulate a procurement strategy, but perma-
nently check and adjust it to ensure continuity. 
Companies have no, or no consistent, coordi-
nated and within the company communicated busi-
ness strategy. Even in large companies, particular-
ly in holding structures, there is a partial lack of a
standardized strategy development process that
takes into account the individual identity and cul-
ture of each subsidiary, as well as the effects of
bundling in the group. This makes it difficult for
the embedded business units, such as procurement,
to shape their business strategies and add value.
Through targeted bundling, the market power of
a company can be sustained and strengthened, and
lead to significant savings effects and other posi-
tive effects (earlier supply, consistent quality, etc.).
Without a general business strategy, there is no
procurement strategy, and thus it is not possible
to integrate effective procurement early. The major-
ity of the following sway factors are directly relat-
ed to the procurement strategy. A clear indication
of this is, for example, the fact that in the
chemical/pharmaceutical sector nearly 59% of the
procurement volume is covered with long-term
contracts. However, according to a BME study, the
rate from framework agreements and catalogs is
well below the industry average (37.6%) (BME, 2012).
3.1.2 Oranization and Procurement Process
In terms of the second sway factor Organiza-
tion and Procurement Process, i.e. swiftness, flexi-
bility and efficiency, the chemical, pharmaceutical
and medical technology cluster received a “satis-
factory” rating (2.8). Of the decision makers in this
sector, 9% “strongly disagree” with the core state-
ment that the procurement process is fast, flexi-
ble and efficient, whereas 9% “entirely agree” with
the statement. The ratings of the majority range
from “somewhat disagree” to “almost entirely
agree”. 
The chemistry/pharmacy sector shows best
practice in terms of the cost per order process. How-
ever, there is potential for improvement regarding
the proportion of orders handled electronically,
including statements (Procure-to-Pay). According
to relevant studies (e.g. BME and University of
Würzburg, 2013), the cost of the procurement
process through e-procurement can be reduced by
at least 30%. This is a potential that is not yet fully
exploited in this industry. 
The ratings in all surveyed industrial sectors
show that procurement activities can be planned
and managed more specifically, and such activities
would eventually lead to a fast, flexible and effi-
cient procurement process, but the organization
of the procurement process should be adapted to
suit the conditions of the company. 
Although the early integration of procurement
requires forward shifting and interlinking of pro-
curement activities with the interface partners, the
early exchange of information allows in return a
more accurate planning and management of pro-
curement activities. Particularly noteworthy is that
the procurement market research and the actual
procurement may run simultaneously with the
planning activities, which can significantly speed
up the procurement process. Through the "early
procurement involvement" it is possible to identi-
fy, assess and manage risks and opportunities ear-
lier. Best practice would be to establish a so-called
"learning organization", in which events are con-
sidered as a stimulus and used in development
processes in order to adapt the knowledge and
capacity to the new requirements. A predictive
cross-functional cooperation between users and
procurement becomes a guarantee for fast, flexi-
ble and efficient procurement processes in the
chemical industry. It is undisputed that there is no
easy solution for this. Rather, the organizational
design of the procurement should be adapted to
the business realities and implemented with regard
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to a particular situation. A process orientation can
be implemented only within flexible organization-
al structures, which are already present in the com-
pany.
3.1.3 Employee Qualification
With regard to the third sway factor Employee
Qualification, the degree of procurement staff qual-
ifications is seen as being predominantly or most-
ly satisfactory. Only 9% of the decision makers in
the chemical, pharmaceutical and medical tech-
nology sector are “completely dissatisfied”, 46%
are “somewhat/reasonably satisfied”, 36%
“mostly/predominantly satisfied” and 9% “com-
pletely satisfied”. 
Since value-oriented procurement has a sub-
stantial impact on a company’s success, qualified,
motivated employees are needed. This can be
achieved through the creation of extensive employ-
ee qualification schemes tailored to suit the com-
pany’s needs and through training courses for pur-
chasers and groups of requisitioners.  
According to a 2013 salary survey conducted by
BME (BME and University of Würzburg, 2013), the
chemical/pharmaceutical industry gives the high-
est annual salaries to procurement managers. How-
ever, this is not directly related to the qualifications
of the procurement staff. The ratios of the BME
study (BME, 2012) show that the costs of profes-
sional training in chemistry/pharmacy per employ-
ee are just above the industry average. If only 9%
of decision makers are "completely satisfied", then
there should be an increased investment in train-
ing to enhance the skills of procurement staff. Only
highly qualified staff is cross-functionally accept-
ed and early involved.
3.1.4 Decision Effiency
The results for the sway factor Decision Efficien-
cy reveal that in the industry cluster for chemicals,
pharmaceuticals and medical technology, 18% of
the respondents do not consider themselves at all
capable of making their decisions “efficiently”,
whereas 18% of them “entirely agree” with the
statement that the decisions for awarding con-
tracts to the suppliers are systematically reached
and documented.
The overall results show that decisions are gen-
erally not sufficiently documented, and that com-
panies should pay more attention to coordinating
and introducing role assignments, ground rules
and reports. 
Decision efficiency and transparency is an
increasingly important component of the role of
procurement within cross-functional teams. When
considering the ever-worsening compliance crite-
ria, it is clearly understandable that an order should
be documented and countersigned to ensure a ver-
ifiable security. Best practice is an independent deci-
sion-making body which examines relevant deci-
sion documents and agrees upon the selection. The
competition among providers can thus be optimal-
ly maintained.
3.1.5 Material Group Management and Cost Trans-
parency
Furthermore, the respondents from the chem-
ical, pharmaceutical and medical technology sec-
tor give their Material Group Management a mid-
table ranking (2.7). Only 9% “strongly disagree” with
the core statement that their procurement depart-
ment has bundled the goods and services to be pro-
cured in a systematic, effective and cost-transpar-
ent manner. The majority of the respondents, 46%
“mostly/almost entirely agree” with the aforemen-
tioned statement. The overall results for this fac-
tor unfortunately show that, although companies
have much knowledge of the goods and services
to be procured, it is rarely documented systemat-
ically and transparently, and there is no progress
in how it is structured further.
The chemistry/pharmacy sector has still room
for improvement in the perception of procurement
responsibility, because the volume which is influ-
enced by procurement is the industry average, while
the rate from closed frame agreements is even sig-
nificantly below the industry average (see figure 1).
Low rates from closed frame agreements point to
weaknesses in the procurement processes or opti-
mization of material group management. Frame
agreements were made, but are not being used
sufficiently by requisitioners or purchasers. There-
fore, improvement and the associated assistance
is also needed in this area.
3.1.6 Supplier Management
Regarding the sway factor Supplier Manage-
ment, the findings in all sectors show that only a
small percentage of the surveyed companies (4%)
made full use of the innovation potential and value-
added reserves of their suppliers. In case of the
chemical, pharmaceutical and medical technology
sector, 9% of the respondents entirely agreed with
that, and half of the respondents thought there is
still considerable potential for improvement in
terms of how procurement can help make work-
ing with suppliers more successful.
However, the potential for enhancing efficien-
cy and effectiveness in procurement has so far only
been used by a few pioneers. Key issues, such as
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supplier management, are poorly implemented.
Thus, it is important to work on developing effi-
cient supplier management systems, and strength-
en the relationship between the manufacturer and
suppliers by assigning them the role of value-adding
partners who will eventually contribute to quality
work outcomes.
3.1.7 Risk Management
The companies in the chemical, pharmaceuti-
cal and medical technology sector gave their Risk
Management a satisfactory grade (2.6). 27% of all
respondents do not believe that they are capable
of taking “mostly” consistent measures to hedge
against risks, whereas 18% “entirely agree” with
the statement that the procurement department
takes steps against risks. The overall results actu-
ally confirm that risks which companies encounter
and have to deal with (risks associated with coun-
tries, branches, currencies, contracts and liabilities)
are still frequently not taken into consideration in
the procurement process, which eventually might
lead to quality issues. Because of that, the procure-
ment department needs to develop a strategy which
would ensure consistent measures which would
reduce or minimize risks. Particularly in relation to
security of supply and maintenance of quality stan-
dards, a continuous monitoring of suppliers is impor-
tant, as it is in respect of commodities e.g. from
politically unstable regions where forecasting is
difficult.
3.1.8 Intensifying Competition
The results for sway factor Intensifying Com-
petition reveal that respondents from all sectors
gave themselves an average grade of 2.5 which is
also the average grade awarded in the chemical,
pharmaceutical and medical technology sector. Of
decision-makers in that sector, 18% “entirely agree”
that their company is familiar with the global mar-
ket and the competitiveness within that market.
36% “mostly/almost entirely agree” with that,
whereas 9% “strongly disagree”. 
The overall results for this sway factor have con-
firmed that there is a substantial number of com-
panies which still have no clear picture of their
national and international procurement markets,
which eventually means that some new procure-
ment markets are not being used and that poten-
tial suppliers have not been identified. Hence, the
focus should be on the use of global supplier mar-
kets and development of intense competition. 
Due to a partial geographical bond, but also
because of the highly specified control and apti-
Figure 1 BME Key Performance Indicators in Purchasing (adapted from BME, 2012).
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tude tests in chemistry, an intensified competition
is expensive, and is only feasible through early
involvement of the quality, research and develop-
ment department. 
The low level of efficiency of online auctions
and sourcing activities in chemistry/pharmacy,
which is slightly above the average in the industry
sectors, indicates that there is a significant untapped
potential in relation to intensifying the competi-
tion. Intensifying competition also includes the use
of e-sourcing and e-auction. The purchasing vol-
ume, which is handled via the aforementioned
methods, can still be improved (see figure 2).
3.1.9 Performance Management
The sway factor Performance Management
received the best average grade in the survey (2.3).
It is interesting that 36% of the respondents in the
chemical, pharmaceutical and medical technology
sector measure and report on their procurement
performance regularly every month. Only 9% never
report on such performance. The overall results
show that a mission for procurement is needed,
and highlight the importance of measuring pro-
curement performance systematically.
The procurement power, i.e. the value contribu-
tion of procurement is mostly properly assessed,
measured and reported to the management by the
procurement managers in the chemical industry.
Adding value to the company's profit is perceived
very well in the chemical sector by other areas of
the company, and also acknowledged, because a
systematic and verifiable measurement of procure-
ment power takes place as part of controlling
involvement.
Reporting instruments and stringent tracking
of measures along a hardness level system are wide-
ly known, but are rarely used in many industries.
However, this is not the case within chemistry. In
addition, there is often a lack of an (within the com-
pany) acknowledged "Savings Guideline" in which
the starting points are defined for the purposes of
properly calculating and measuring procurement
performance. A particular challenge in the chemi-
cal/pharmaceutical industry is the clear distinction
of the starting points due to the volatile markets.
Windfall profits or the increase of commodity prices
such as oil are to be reported or eliminated. Costs
for risk hedging purposes could be considered.
Essential for this is the previously established “Sav-
ings Guideline” and a careful selection of absolute
and relative indicators to identify changes and
trends, and take appropriate control measures with-
in and outside the organization.
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Figure 2 BME Key Performance Indicators in Purchasing (adapted from BME, 2012).
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3.2 Position in the ConMoto Maturity Model for
Value-oriented Procurement
Based on the findings of their survey, ConMo-
to has developed a maturity model for value-ori-
ented procurement, in which they have classified
companies into different levels (ConMoto Consult-
ing Group GmbH, 2012):
Level I “Disorganized”: Procurement processes
are disorganized and not clearly defined. The
procurement process is often initiated by the
requisitioner, i.e., it is decentralized (= Maver-
ick Buying).
Level II “Reactive”: Procurement is reactive and
there is not sufficient market research. Here,
procurement functions as a clerk’s office and
has no influence on the procurement decision,
which was already pre-empted by the requisi-
tioner. There is no active control system through
procurement.
Level III “Active”: Procurement structures are
defined. The procurement has still no large con-
trol function. Bundling through projects and
throughout the sectors does not occur. Howev-
er, there are some proactive bids for required
scope.   
Level IV “Networked Mover and Shaker”: Pro-
curement plays an important role within the
company, and is aware of the company’s con-
tacts to suppliers.
Procurement is included early in the requisition
processes and may help create and control.
Requirements can thus be bundled through
projects and throughout the sectors. Procure-
ment is an accepted partner both internally and
in communication with the suppliers.
Level V “Performer”: A sourcing committee has
been established, and the decisions are reached
collectively. Procurement department is a process
driver. The procurement strategy is in line with
the corporate strategy and the processes are
efficient, coordinated and lived throughout.
Level VI “Innovative Value Provider”: Decision
efficiency is at the highest possible level. Pro-
curement department shapes processes and is
not only an innovator, but a value driver as well.
Suppliers are also part of the innovation process.
The procurement strategy is optimized contin-
uously. Procurement is a learning organization.
In short, it can be stated that Level I-III can con-
tribute only limitedly with their hard-earned sav-
ings. A long-term increase in value does not start
until Level IV, in fact it is supported by the use of
all procurement leverages:
Increase in operating income by reductions in
the cost of capital
Targeted reductions in the cost of materials and
manufacturing
Streamlining of business processes
Contribution to sustainable profitable revenue
growth by utilizing the innovation  power of
suppliers and thus ensuring competitiveness
Reduced time-to-market and reaction time.
As it can be seen in figure 3, the levels are fur-
ther grouped into three categories: “Bringing up
the Rear” (Level I and Level II), Midtable (Level II and
Level IV) and Leading Group (Level V and Level VI).
Regarding the chemical, pharmaceutical and
medical technology sector, the respondents rated
their procurement as “satisfactory”, and therefore
this sector falls into the Level IV category of “Net-
work Mover and Shaker” in the maturity model,
which means that it has an upper mid-range rank-
ing. It also implies that there is still work to do
before it can reach the best level, i.e. “Innovative
Values Provider”. Another interesting fact in terms
of the grades awarded for the core sway factors is
that the spread of the grades for best (1.1) and worst
(4.9) rated companies is most prominent in this
sector.
The ConMoto Maturity Model shows the gen-
eral state of the chemical industry in the overall
economy among the companies surveyed. The sur-
vey of top management participants in the indus-
try sector "chemistry" shows that there is still a lot
to improve, and enormous potential could be gen-
erated through the procurement and its setting
and value in the company. The conducted study has
confirmed the practical knowledge gained through
numerous projects in chemistry, and has given fur-
ther insights in the approach and potential for
improvement.
4 The Succes Factors
4.1 Twelve success factors 
Based on their experience and engagement in
projects, ConMoto’s procurement experts have
highlighted the success formula for procurement,
i.e. the twelve core components which lead to first-
rate value-oriented procurement. These twelve fac-
tors should be regarded in individual contexts and
should be adapted to the company’s specific situ-
ation (ConMoto Consulting Group GmbH, 2012).
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1. Strategy and Implementation Expertise
It is essential to develop a corporate strategy
which will then impact the procurement strat-
egy. Without the procurement strategy there
are no common goals and thus no targeted con-
trol of the employees. The strategy elements
and fields of action which need to be taken into
consideration, include customer requirements,
vision, mission, basic conditions, goals, respon-
sibilities and deadlines, budget and target agree-
ments. In order to successfully pursue these ele-
ments, it is important to report any deviations
as soon as they occur. The strategy must be coor-
dinated efficiently and be in line with the man-
agement. Adjustments and optimization must
occur in the context of a learning organization.
2. Decision Efficiency
The procurement department plays an impor-
tant role in the process of make-or-buy deci-
sions, innovation, product emergence and the
general procurement process. It is involved in
improving decision efficiency by establishing a
sourcing committee. This body needs to reach
important decisions in terms of assigning tasks
and awarding contracts. It is important that the
committee is composed of members of depart-
ments involved in the process, and that all mem-
bers are equal, so that the decisions and the
impact of decisions are equally shared. Howev-
er, procurement has to play the leading role in
this committee in terms of processing all deci-
sion documents.
3. Financial Management
Savings guidelines are being introduced in order
to measure procurement success transparent-
ly. These guidelines enable the calculation of
financial procurement performance one year
in advance. However, it is necessary to coordi-
nate this calculation, which means that more
departments, i.e. controlling, finance and pro-
curement departments, need to cooperate in
preparing and performing the calculation.
A commonly agreed savings guideline prevents
differences in the measurement and represen-
tation of procurement services. This increases
the acceptance and appreciation of procure-
ment within a company. A savings guideline is
an absolute requirement for performance meas-
urement in relation to the objectives set in the
strategy.
4. Change Management
Due to market changes, the management
process also undergoes changes. This calls for
the procurement department to adapt to such
new requirements by changing basic conditions,
processes and goals. This assumes taking inter-
nal customer requirements into consideration.
New approaches should be developed and
agreed upon together with the internal cus-
tomer, so that these approaches are then actu-
Figure 3 ConMoto Maturity Model for Value-oriented Procurement (ConMoto Consulting Group GmbH, 2012).
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ally adapted and lived. If solutions were imposed,
the internal customer would feel “hindered”,
and assume a defensive approach. Early inte-
gration and communication are here the alpha
and omega, and thus essential for success.
5. Organizational Quality
The procurement department is a learning
organization, which means that it adapts its
organization to its internal customers. This up-
to-date approach leads to improvements regard-
ing work instructions and organizational guide-
lines.
Here, procurement should be considered as the
"driver seat" and again contribute to sugges-
tions, as well as support suppliers to enhance
innovation management. Suppliers can be dis-
seminators of innovative ideas and solutions.
6. Human Resource Management
The procurement staff is an important force
within the company, and therefore needs to be
provided with comprehensive and specific train-
ing which will develop their qualifications. Such
training will enhance the performance-orient-
ed component, efficacy, and efficiency of the
staff. In order to develop the most appropriate
training and continue to play the role of active
“Movers and Shakers”, the procurement staff is
regularly monitored and evaluated.
ConMoto has developed one such specific train-
ing program, i.e. “QAMPUS”, which includes
“Basic”, “Professional” and “Excellence” mod-
ules. These modules help employees meet their
challenges and needs. Valuable theoretical
approaches are underpinned here, with many
practical examples and application exercises,
and upon request developed in cross-function-
al teams and deepened together. This fosters
cross-departmental communication and under-
standing of the respective roles within the com-
pany.
7. Quality Performance
The procurement department monitors the
quality performance through a quality assur-
ance system, and implements the received data
into its sourcing decisions. If any problems with
suppliers occur, the procurement department
will assist staff in quality assurance. Quality per-
formance is also an important part of supplier
management and can, in the worst case, gen-
erate very high unwanted costs (delays, com-
plaints, product recalls, loss of reputation, etc.).
8. Supplier Management
The procurement department possesses rele-
vant data regarding the suppliers which they
receive through researching the market, i.e. the
global procurement market, and reviewing com-
petitiveness of its suppliers. The competitive
environment of suppliers is used by procure-
ment to attain competitive advantage.
But also shortening the delivery time, process
improvements, quality improvements can be
worked out together with the suppliers and lead
to ensuring competitiveness. The development
of new suppliers is part of the supplier man-
agement and is essential for a long-term coop-
eration.
9. Innovative Capacity
Product innovation and progress is also pursued
by the procurement department. It conducts
research in order to follow the developments
on the supplier market. Such developments are
then integrated into the company’s own pro-
duction development process.
10. GRC Management (Corporate Governance,
Risk Management, Compliance)
The procurement department is also part of the
risk management system which tries to prevent
any delivery failure. The staff aims at applying
regulations which will prevent potential con-
flicts and risks. If a deviation occurs, it is record-
ed and corrected. GRC plays a major role with
respect to the image both internally and exter-
nally, which again is important for the area of
public relations.
11. Contract Management
Regarding contractual negotiations with sup-
pliers, the procurement department plays the
central role. The contracts are stored and
processed electronically, and their content is
reviewed in order to check whether they are in
agreement with the rules. Compliance and trans-
parency are here the top criteria, which can only
be achieved through centralized contract man-
agement. An alert function supports early renew-
al, extension or early termination of contracts.
Duplicates and incorrect versions of contracts
are prevented.
12. IT / Data Management
An IT strategy plan also enhances the procure-
ment processes, and thus procurement staff is
trained to use the latest communication sys-
tems. All data structures are up-to-date and in
accordance with industrial standards. IT require-
ments and standards are to be agreed upon and
set by an expert panel, so that they can be bun-
dled through frame agreements and negotiat-
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ed centrally. Another field can be more opti-
mized through e-procurement, e-sourcing and
e-auctions. Standardized procurement process-
es can be depicted through portal or cloud solu-
tions, and safely and efficiently handled. Inte-
grated electronic procurement systems also
support the supplier management (training,
evaluation, development), catalog management
for C items (i.e. marginally important items for
an organization in terms of their value and con-
tribution to making profit), the spend manage-
ment and contract management. E-sourcing
simplifies the procurement market research,
and all RFX processes1 and e-auctions increase
competition.
4.2 Success factors in chemical, pharmaceutical
and medical industry
Success factors, for which the chemical/phar-
maceutical industry received the lowest grades,
offer conversely the largest potential for improve-
ment:
According to the findings of the study, compa-
nies in the chemical, pharmaceutical and medical
industry were ranked 8 of 8 in terms of Procure-
ment Strategy, and thus placed at the bottom. Many
small and midsize companies do not have or have
no consistently coordinated business strategy from
which, by taking into account the situation on the
procurement market, the procurement strategy
would be derived. The respective strategy compo-
nents are to be developed together with all respon-
sible persons in order to provide a systematic and
standardized methodology and definition of suc-
cess factors which the companies often lack.
Regarding the factor Decision Efficiency com-
panies in the chemical, pharmaceutical and med-
ical industry have still much optimization poten-
tial to generate, because after the analysis of the
study in this area they were positioned at the bot-
tom (ranked 8 of 8).
The most important point along the procure-
ment process is the decision on awarding contracts
to suppliers which would consider prices, condi-
tions and a defined scope. Frequently, contract
award decisions are not directly made by the pro-
curement department, but the specialist areas make
sure that specific suppliers' products and services
will meet their requirements. There also might be
some dependency on patents, subscription rights
or tools owned by suppliers. Thus, not the best deci-
sion for the company is made, but individual inter-
ests of a department are considered. Contract award
decisions are often not transparent and not suffi-
ciently documented.
According to the study, the results for the fac-
tor Performance Management are much better in
the chemical, pharmaceutical and medical indus-
try. In this occasionally essential area, there is much
room for improvement (rank 6 out of 8) to strength-
en coordinated Performance Management. The
mission and the function of procurement is often
not clearly defined and coordinated. A „Mission
Statement“ exists only rarely.
Procurement performance, i.e., the value-added
procurement, is correctly assessed by responsible
persons in procurement, but is rarely measured and
reported to the company's management. In this
way, this added value is not perceived by other busi-
ness areas, nor will it be acknowledged, unless there
is a systematic and verifiable measurement of pro-
curement performance.
5 Conclusion
In the ConMoto Study, companies that operate
in the chemical, pharmaceutical and medical indus-
try show their weak points in different areas of pro-
curement, but in turn have potential for the fol-
lowing areas, which will especially be reflected in
the results of the company:
From the findings of the study and through an
adapted methodology in the chemical, pharma-
ceutical and medical technology sector, the foun-
dation of a professional procurement is an inte-
grated, within the company coordinated and com-
municated procurement strategy, which takes into
account the individual identity and culture of each
subsidiary, as well as effects of bundling in the
group. Accordingly, a systematic methodology is to
be applied, and success factors should be defined.
In order to define the delegation of decision-
making, an awarding body, i.e. a sourcing commit-
tee, in which all partners involved in the process
would participate and have full voting rights, should
be established. A distinction between, on one hand,
the operational procurement and negotiation activ-
ities, and on the other hand, the actual contract
award decision would be perfect. Introducing role
assignments, ground rules and reports are not to
be underestimated
In order to produce regular reports on procure-
ment performance for the management of the
company, reporting tools and a stringent pursuit
of measures should be enhanced. However, there
is also a need for a “Savings Guideline” acknowl-
edged within the company, in which the starting
points for an unambiguous calculation and evalu-
ation of procurement performance would be
defined. The status of procurement within the com-
pany is also increased through regular communi-
1)   RFX is an acronym used in the sourcing marketplace, and stands for Request for Information (RFI), Request for Proposal (RFP) and/or Request for Quote (RFQ).
cation of procurement performance and the con-
tribution to the company’s profit.
Due to the interdependence of corporate strate-
gies and procurement strategies, it is necessary to
coordinate the persons involved in the procure-
ment process, and to avoid any information asym-
metries within the company. Consequently, they
will develop a high sense of responsibility. It is also
beneficial and has a positive impact on the process
itself when authorized persons are involved from
the beginning of the process.
To achieve procurement potential through the
conscious development of an elaborated supplier
management, is one of the key points of a procure-
ment potential analysis. For a comprehensive opti-
mization, together with other areas in the compa-
ny, (cross-functional) integrated approaches to opti-
mize the collaboration within the company are to
be developed. Only through a long-term orienta-
tion of processes and structures towards the prin-
ciples of the company and a trustful cooperation
with synchronous use of the competitive situation,
the full savings potential can be achieved. For this
purpose, the procurement potential analysis serves
the objective to observe and, for different product
groups, implement the most efficient material
group strategy with different levels of cooperation
intensities by the staff. Prerequisites for achieving
these objectives are the intensive use of the sup-
plier's know-how and the creation of problem-solv-
ing capacity in procurement and its integration
into the overall corporate image. 
Likewise, the training, assessment and devel-
opment of suppliers pose a far underrated contri-
bution to generating potentials. These three levels
provide the basis for quality assurance, price nego-
tiations and deriving the consequences from the
assessment. The vertical range of manufacture in
companies is steadily being reduced, which leads
to the fact that the procurement volume is between
40-70% of the turnover, and that reflects the increas-
ing importance of the procurement department
and supply chain management (BIP "Best in Pro-
curement", 2011).
In spite of its significance in terms of contribut-
ing to the company’s value, many companies have
still not fully realized the value-added potential of
procurement and, unfortunately, have not imple-
mented a first-rate value-added procurement man-
agement system. The sooner they identify its sig-
nificance, the earlier it can contribute to their own
success. In order to pursue that goal, companies
should focus on the success factors which will help
them work towards value-oriented procurement
as well as define future tasks and fields of action
using the best in the industry as their benchmark.
Not only cost reductions, but also quality improve-
ments, product modifications, reduction of produc-
tion, throughput, and delivery time can be initiat-
ed by procurement and performed collectively in
cross-functional teams (BIP "Best in Procurement",
2011).
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